Martek Biosciences Corporation
Company Income Statement
| Oct 2007 | Oct 2006 | Oct 2005 | Oct 2004 | |
| Sales | 306.81M | 270.65M | 217.85M | 184.49M |
| Cost of Sales | 173.41M | 151.60M | 116.89M | 106.31M |
| Gross Operating Profit | 133.40M | 119.05M | 100.96M | 78.19M |
| Selling, General, and Administrative Expenses | 24.85M | 24.82M | 20.47M | 18.60M |
| Research & Development | 46.47M | 42.77M | 41.06M | 29.77M |
| Operating Income before D & A (EBITDA) | 62.08M | 51.46M | 39.44M | 29.82M |
| Depreciation & Amortization | 26.47M | 17.15M | 16.49M | 8.69M |
| Interest Income | 1.14M | 1.49M | 1.43M | 579.00K |
| Other Income - Net | 0.00 | 0.00 | 0.00 | 193.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 35.90M | 31.07M | 24.37M | 21.90M |
| Interest Expense | 2.23M | 3.02M | 303.00K | 0.00 |
| Pre-Tax Income | 33.67M | 28.05M | 24.07M | 21.90M |
| Income Taxes | 1.66M | 10.24M | 8.79M | -25.15M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 32.01M | 17.81M | 15.28M | 47.05M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 32.01M | 17.81M | 15.28M | 47.05M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 32.01M | 17.81M | 15.28M | 47.05M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
32.87M | 22.54M | 15.28M | 47.05M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 32.01M | 17.81M | 15.28M | 47.05M |
| Basic EPS from Continuing Ops. | 0.99 | 0.55 | 0.49 | 1.62 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.99 | 0.55 | 0.49 | 1.62 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.99 | 0.55 | 0.49 | 1.62 |
| Basic Normalized Net Income/Share | 1.02 | 0.70 | 0.49 | 1.62 |
| EPS fr Continuing Ops. | 0.98 | 0.55 | 0.48 | 1.55 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.98 | 0.55 | 0.48 | 1.55 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.98 | 0.55 | 0.48 | 1.55 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.01 | 0.70 | 0.48 | 1.55 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas